Mechanism of Coralyne-mediated DNA Photo-nicking Process
Overview
Authors
Affiliations
Previously, we reported that coralyne and UVA combination sensitized a wide range of human carcinoma cells regardless of their p53 status. The coralyne induced photosensitization of cancer cells may be clinically attractive, as mutation in the p53 gene is prevalent in many types of tumors. Coralyne mediated photosensitization of cancer cells is attributable to its ability to cause extensive DNA single strand breaks (SSB). However, the precise mechanism of coralyne induced DNA photo-damage is not yet known. The present study was aimed to understand the hitherto unknown mechanism of the coralyne-induced DNA photo-cleavage process. To this end, we compared the DNA photo-nicking properties of berberine, jatrorrhizine and coralyne, and deciphered involvement of the photochemical processes in the photo-nuclease action of coralyne using absorption and electron spin resonance spectroscopy, high performance liquid chromatography and mass spectroscopy (MS) techniques in conjunction with relevant in vitro studies with plasmid DNA. In association with UVA, coralyne, but not berberine and jatrorrhizine induced significant nicking of plasmid DNA via an O-independent photo-chemical process. The Job's plot of our spectrophotometric data suggested that one coralyne molecule remains intercalated with two DNA base pairs (i. e., 1:2) and starts forming aggregates beyond this molar ratio. The DNA photo-nicking by the combination of coralyne and UVA (designated as CUVA) was primarily caused by the coralyne aggregates without any significant contribution from the DNA-intercalated coralyne monomer.
Schlosser J, Fedorova O, Fedorov Y, Ihmels H Beilstein J Org Chem. 2024; 20:101-117.
PMID: 38264449 PMC: 10804566. DOI: 10.3762/bjoc.20.11.
Wickhorst P, Ihmels H, Paululat T Molecules. 2021; 26(21).
PMID: 34771003 PMC: 8587938. DOI: 10.3390/molecules26216595.
Research progress of berberine mediated photodynamic therapy.
An Y, Jin H, Yuan B, Wang J, Wang C, Liu H Oncol Lett. 2021; 21(5):359.
PMID: 33747216 PMC: 7967931. DOI: 10.3892/ol.2021.12620.